Patent · US Active

Diagnostic method for identifying carriers of the Marburg I variant of factor VII-activating protease (FSAP) on the basis of differential modulation of FSAP activity

US7943333B2 · kind B2 · utility

0Cited by

1References

19Claims

0Family size

Assignee

Siemens Healthcare Diagnostics Products GmbH · DE

Inventors

Frank Vitzthum · Lahntal, DE
Herbert Schwarz · Niedereschach, DE

Key dates

Filing date	Dec 21, 2006
Grant date	May 17, 2011
Priority date	—
Expiry date	Nov 12, 2028

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/96447
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to a diagnostic method for identifying persons with genetically related hetero- or homozygous expression of the MR I variant of factor VII-activating protease (FSAP). The heterozygous or homozygous presence of an MR I polymorphism can be identified by a differential modulation of the FSAP activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.